In T2D patients, B cells constitutively secrete the pro-inflammatory chemoattractant IL-8, while also secreting lower levels of IL-10, TNFα, and IL-6 than non-diabetic controls (13). The gene discussed is TNF; the disease is type 2 diabetes mellitus.